Medication info
Procyta 25 mg (Sitagliptin Hydrochloride Hydrate)

Procyta 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Aju Pharmaceuticals Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP*2]
Approval status
Active

MFDS item code 202101370 · Approved 2021.02.17 · Insurance code 654006090

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medication is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (refer to Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Aju Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood glucose control in patients with type 2 diabetes
View approved original text

This medication is used for effectively controlling blood glucose in patients with type 2 diabetes. It can be administered alone or in combination with other diabetes medications such as metformin, sulfonylureas, thiazolidinediones, or insulin as needed. Combination therapy is particularly recommended for patients with no prior experience of diabetes medication treatment or who have difficulty achieving sufficient blood glucose control with monotherapy. It enhances therapeutic effects when used additionally in patients who have difficulty controlling blood glucose with various combination therapies. This treatment helps improve blood glucose control and assists in managing diabetes.

How to take

Adult dose

This medication is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (refer to Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medication and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. In patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. In patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medication may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions in some patients; if skin rash, difficulty breathing, or swelling of the face or neck occurs, discontinue use immediately and consult a physician. While taking this medication, serious pancreatic inflammation known as pancreatitis may occur; if abdominal pain, nausea, or vomiting occurs, visit a hospital immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and patients with hypersensitivity to this medication or its components should also refrain from use. Patients with impaired kidney function need to have their dosage adjusted, so regular kidney function tests should be conducted, and the medication should be taken as directed by a physician. Taking this medication with other blood glucose-lowering agents may increase the risk of hypoglycemia, so caution is advised regarding hypoglycemia symptoms when used in combination with insulin or sulfonylureas, and dosage adjustments may be necessary. While taking this medication, side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea, and abdominal pain may occur; if symptoms are severe or persistent, consult healthcare providers. If severe joint pain or blistering skin disorders occur, stop taking the medication immediately and consult a doctor. It is advisable for pregnant or breastfeeding women to avoid using this medication, and safety and efficacy have not been established in children or adolescents under 18 years of age. Elderly patients may risk impaired kidney function, thus kidney function should be monitored before and after taking this medication to ensure caution. In case of overdose, visit a medical facility immediately for appropriate treatment, and this medication can be partially removed via hemodialysis. This medication has minimal drug interactions, but caution is necessary when used with specific medications, so it's important to inform the doctor or pharmacist of any other medications being taken. If unusual reactions or uncomfortable symptoms occur while taking this medication, it's essential to consult healthcare providers promptly.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and debilitating arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it's best kept at room temperature between 1°C and 30°C. Proper storage maintains the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.